Monopoly 2.0 - Dealing with dominance in today's digital economy and life-sciences sectors
Stockholm
11 - 13 June 2020
In June 2020 Stockholm will host the AIJA conference titled ‘Monopoly: 2.0, dealing with dominance in today's digital economy and life-sciences sectors'. This joint seminar organised by the AIJA Antitrust Commission in cooperation with the AIJA Healthcare & Life-Sciences Commission will focus on ‘dominance’ and its consequences, rethinking the concept and the definition of market power in a global and digital economy and in markets that are rapidly changing, in particular also addressing the life-sciences sector.
With great power comes great responsibility. This century old adagium is very much alive in antitrust policy and enforcement. The most recent developments will be tackled, including antitrust enforcers' approach to BigTech across the globe, platform-to-business relationships, the interplay between competition laws and privacy regulation, the rise of eco-systems as well as merger control developments.
The healthcare and life sciences break-out sessions will compare how important issues related to purchases of pharmaceutical products are handled around the world and use this unique opportunity to assess how competition law affects healthcare and life sciences.
Join us in Stockholm to learn and debate these trending topics! The academic programme will be complemented by a rich social schedule, with a chance to see Stockholm from the seaside and excellent opportunities to meet and see old and new friends.
AIJA Commissions
- Antitrust
- Healthcare and Life Sciences
Event fees
| + VAT if applicable | <= 2020-04-08 | > 2020-04-08 | |
| AIJA Member < 35 | 4500,00 SEK | 5285,00 SEK | |
| AIJA Member >= 35 | 5025,00 SEK | 5810,00 SEK | |
| Non AIJA Member < 35 | 5545,00 SEK | 6330,00 SEK | |
| Non AIJA Member >= 35 | 6070,00 SEK | 6855,00 SEK | |
| Speaker | 4500,00 SEK | 5285,00 SEK | |
| Local lawyers | 4500,00 SEK | 5285,00 SEK | |
| In-House Counsel | 1570,00 SEK | 1570,00 SEK | |
Programme complet
Antitrust Track
Thursday 11 June 2020
Address: Östra Järnvägsgatan 35, 111 20 Stockholm, Sweden
Address: Östra Järnvägsgatan 35, 111 20 Stockholm, Sweden
Friday 12 June 2020
Address: Östra Järnvägsgatan 35, 111 20 Stockholm, Sweden
Introduction: Academic background and introduction to the main challenges in rapidly evolving markets
Moderator:
Sofia Falkner, Hammarskiöld, Sweden
Speakers:
Judith Feldner, Eisenberger & Herzog, Austria
Karan Chandhiok, Chandhiok & Associates, India
- Is the current legal framework sufficient to assess market power/ whether a monopoly exists, or do we need a new approach??
- Where does disruption or innovation equal dominance?
- Can we still apply traditional methods for the definition of markets that are innovative and rapidly changing or do we need sector-specific rules (in particular for pharmaceutical)?
- What kind of behaviour may constitute an abuse of a dominant position?
Sebastian Janka, Luther, Germany
Speakers:
Daniel Emch, Kellerhals, Switzerland
Renaud Christol, August Debouzy, France
Ludovica Pizzetti, Anold Porter, UK/Italy
Blaz Visnar, European Commission / DG Competition (Unit E/1 - Antitrust Pharma and Health services), Belgium
- Narrow definition of markets for pharmaceutical products – Is every innovative producer a dominant?
- Pay-for-delay abuse of dominance
- Market definition and dominance contra innovation and pipeline products
- Practical aspects of producers of dominant drugs in the moment of patent expiration
- The use of interim measures – pro's and con's
- Is the current toolbox sufficient under Monopoly 2.0?
Johanna Svantesson, DLA Piper, Sweden
Speakers:
Virginie Kurtz, Swedish Competition Authority, Sweden
Frank Bremer, Schellenberg Wittmer, Switzerland
Michel Alexander, Smith & Williamson, United Kingdom
Kristian Hugmark, Roschier, Sweden
Saturday 13 June 2020
- How to regulate BigTech if not breaking them up
- Regulation fuelling BigTech - the paradox
- Competition instead of regulation - the free-market argument
Johan Wahlbom, Vinge, Sweden
Speakers:
Gustavo Flausino Coelho, Coelho Vasques Advogados, Brazil
Andrea Pomana, Debevoise, Germany
Jorge ManzarbeitIa, Callol Coca & Asociados, Spain
- “New” competitive problems regarding platforms as two-sided markets / Access to data
- Data protection as a new competitive concern for internet “giants” such as Facebook
- Network effects 2.0: Mergers of platforms (e.g. Dating & Real Estate)
Sophie Gilliam, DLA Piper, Netherlands
Speakers:
Aleksandra Dziurkowska, WKB Wierciński, Kwieciński, Baehr Sp. k., Poland
Amandine Gueret, Hausfeld & Co. LLP, UK
Christoph Weinert, Commeo LLP, Germany
German Zakharov, ALRUD Law Firm, Russia
Healthcare and Life Sciences Track
Thursday 11 June 2020
Address: Östra Järnvägsgatan 35, 111 20 Stockholm, Sweden
Address: Östra Järnvägsgatan 35, 111 20 Stockholm, Sweden
Friday 12 June 2020
Address: Östra Järnvägsgatan 35, 111 20 Stockholm, Sweden
Introduction: Academic background and introduction to the main challenges in rapidly evolving markets
Moderator:
Sofia Falkner, Hammarskiöld, Sweden
Speakers:
Judith Feldner, Eisenberger & Herzog, Austria
Karan Chandhiok, Chandhiok & Associates, India
- Is the current legal framework sufficient to assess market power/ whether a monopoly exists, or do we need a new approach??
- Where does disruption or innovation equal dominance?
- Can we still apply traditional methods for the definition of markets that are innovative and rapidly changing or do we need sector-specific rules (in particular for pharmaceutical)?
- What kind of behaviour may constitute an abuse of a dominant position?
Moderator:
Sebastian Janka, Luther, Germany
Speakers:
Daniel Emch, Kellerhals, Switzerland
Renaud Christol, August Debouzy, France
Ludovica Pizzetti, Anold Porter, UK/Italy
Blaz Visnar, European Commission / DG Competition (Unit E/1 - Antitrust Pharma and Health services), Belgium
- Narrow definition of markets for pharmaceutical products – is every innovative producer a dominant?
- Pay-for-delay abuse of dominance
- Market definition and dominance contra innovation and pipeline products
- Practical aspects of producers of dominant drugs in the moment of patent expiration
- Current status – What is in place and what is missing?
- Update from the authorities
- The death of small med-tech companies and start-ups?
- How to mitigate risk in the yet uncertain fields
- Brexit
Speakers:
Mary Cooney, Mason Hayes & Curran, United Kingdom
Åsa Runnäs, Clarvin AB, Sweden
Elisabeth Liljensten, Devicia AB, Sweden
Saturday 13 June 2020
I. Patient’s legal right to free healthcare vs public interest on financial stability of the healthcare system (in the world of new super expensive pharmaceutical products)
a) Is there a limit on costs per patient, i.e. on his legal right to free healthcare?
b) Who decides?
c) Does the patient have a judicial recourse?
d) Do patients have access to pharmaceutical products without set reimbursement and/or maximal price? Under what circumstances?
Moderator:
Tímea Halkó, Gedeon Richter Plc, HUNGARY
Speakers:
Barbora Vrablova, Holubova advokati, Czech Republic
Ruben Masar, Vischer AG, Switzerland
Marcel Boller, Wenger&Vieli AG, Switzerland
Renato Bucher, Meyerlustenberger Lachenal, Switzerland
Speakers:
Janine Reudt-Demont, Niederer Kraft Frey, Switzerland
Davide Alemanni, Gianni-Origoni-Grippo-Capelli, Italy
Marcel Hajd, Marifarm, Slovenia
Elisa Stefanini, Portolano Cavallo, Italy
Seminar session 6.2: Purchasing pharmaceutical products – interactive session- mock constitutional trial
Patient in need of super expensive cure suing his public sick-fund
Sponsors
PLATINUM
GOLD
Become a sponsor
If you are interested in becoming a sponsor, please fill out the form*.
You can download the sponsorship brochure after submitting this form.
* Filling out this form does not obligate you to become a sponsor.
Informations pratiques
Accommodation
Please book your room at Clarion Hotel Sign prior to 10 May 2020 via this form
Hotel address: Östra Järnvägsgatan 33, Norrmalm, 101 26 Stockholm, Sweden
Rate: Double room for Single Occupancy (1 Guest) (incl. breakfast and VAT): 161€ / night
AIJA Registration Cancellation Policy
Up to 6 weeks before the event: Refund of 100% of the registration fees paid
deducted by an administrative fee of 50 EUR
Up to 2 weeks before the event: Refund of 50% of the registration fee paid
deducted by an administrative fee of 50 EUR
Less than 2 week before the event: No refund
Comité organisateur
Martin ABRAHAM
Abraham & Partneri, advokatni kancelar s.r.o. (CZECH REPUBLIC)
Sofia FALKNER
Advokatfirman Hammarskiöld & Co AB (SWEDEN)
Sophie GILLIAM
DLA Piper Nederland N.V. (NETHERLANDS)
Tímea HALKO
Gedeon Richter Plc. (HUNGARY)
Siri MåRTENSSON
Advokatfirman Morris AB (SWEDEN)
Boris OSTROUKHOV
ALRUD Law Firm (RUSSIAN FEDERATION)
Beatrice STANGE
Heuking Kühn Lüer Wojtek PartmbB (GERMANY)
Johanna SVANTESSON
Advokatfirma DLA Piper Sweden KB (SWEDEN)
Ewan TOWNSEND
Arnold & Porter (UNITED KINGDOM)
Johan WAHLBOM
Advokatfirman Vinge KB (SWEDEN)
